As of Mar 23
| -0.24 / -1.37%|
The 4 analysts offering 12-month price forecasts for Spectrum Pharmaceuticals Inc have a median target of 27.50, with a high estimate of 33.00 and a low estimate of 25.00. The median estimate represents a +59.24% increase from the last price of 17.27.
The current consensus among 4 polled investment analysts is to Buy stock in Spectrum Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.